# Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs

> **NCT00816673** · PHASE2 · COMPLETED · sponsor: **Neurim Pharmaceuticals Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Primary Insomnia

## Interventions

- **DRUG:** placebo Circadin
- **DRUG:** Circadin

## Key facts

- **NCT ID:** NCT00816673
- **Lead sponsor:** Neurim Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-09
- **Primary completion:** 1997-05
- **Final completion:** 1997-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816673, "Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00816673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*